• Ferrer RocaRRServicio de Medicina Intensiva del Hospital Vall d́Hebron, Barcelona, España. Electronic address: r.ferrer@vhebron.net., J C Sánchez Salado, M Chico Fernández, J M García Acuña, A Lesmes Serrano, E López de Sá, and J Roldán Ramírez.
• Servicio de Medicina Intensiva del Hospital Vall d́Hebron, Barcelona, España. Electronic address: r.ferrer@vhebron.net.
• Med Intensiva. 2021 Apr 1; 45 (3): 164-174.

AbstractTargeted temperature management (TTM) through induced hypothermia (between 32-36 oC) is currently regarded as a first-line treatment during the management of post-cardiac arrest patients admitted to the Intensive Care Unit (ICU). The aim of TTM is to afford neuroprotection and reduce secondary neurological damage caused by anoxia. Despite the large body of evidence on its benefits, the TTM is still little used in Spain. There are controversial issues referred to its implementation, such as the optimal target body temperature, timing, duration and the rewarming process. The present study reviews the best available scientific evidence and the current recommendations contained in the international guidelines. In addition, the study focuses on the practical implementation of TTM in post-cardiac arrest patients in general and cardiological ICUs, with a discussion of the implementation strategies, protocols, management of complications and assessment of the neurological prognosis.Copyright © 2020 The Authors. Publicado por Elsevier España, S.L.U. All rights reserved.

9 keywords...

hide…